Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, originally known by OMP-131R10, is a new monoclonal immunoglobulin engineered to inhibit granulocyte-macrophage colony-stimulating FMS-like tyrosine kinase. https://www.targetmol.com/compound/rosmantuzumab